Literature DB >> 18992329

Alternative splicing and disease.

Jamal Tazi1, Nadia Bakkour, Stefan Stamm.   

Abstract

Almost all protein-coding genes are spliced and their majority is alternatively spliced. Alternative splicing is a key element in eukaryotic gene expression that increases the coding capacity of the human genome and an increasing number of examples illustrates that the selection of wrong splice sites causes human disease. A fine-tuned balance of factors regulates splice site selection. Here, we discuss well-studied examples that show how a disturbance of this balance can cause human disease. The rapidly emerging knowledge of splicing regulation now allows the development of treatment options.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992329      PMCID: PMC5632948          DOI: 10.1016/j.bbadis.2008.09.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  186 in total

1.  Alu-containing exons are alternatively spliced.

Authors:  Rotem Sorek; Gil Ast; Dan Graur
Journal:  Genome Res       Date:  2002-07       Impact factor: 9.043

Review 2.  Cryo-electron microscopy of spliceosomal components.

Authors:  Holger Stark; Reinhard Lührmann
Journal:  Annu Rev Biophys Biomol Struct       Date:  2006

Review 3.  Altered splicing in prelamin A-associated premature aging phenotypes.

Authors:  Annachiara De Sandre-Giovannoli; Nicolas Lévy
Journal:  Prog Mol Subcell Biol       Date:  2006

Review 4.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

5.  Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms.

Authors:  Pedro R Romero; Saima Zaidi; Ya Yin Fang; Vladimir N Uversky; Predrag Radivojac; Christopher J Oldfield; Marc S Cortese; Megan Sickmeier; Tanguy LeGall; Zoran Obradovic; A Keith Dunker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

6.  An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy.

Authors:  Natalia N Singh; Elliot J Androphy; Ravindra N Singh
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

7.  hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.

Authors:  Tsuyoshi Kashima; Nishta Rao; Charles J David; James L Manley
Journal:  Hum Mol Genet       Date:  2007-09-19       Impact factor: 6.150

8.  Quantitative analysis of tau isoform transcripts in sporadic tauopathies.

Authors:  J W Connell; T Rodriguez-Martin; G M Gibb; N M Kahn; A J Grierson; D P Hanger; T Revesz; P L Lantos; B H Anderton; J-M Gallo
Journal:  Brain Res Mol Brain Res       Date:  2005-03-29

9.  The transcriptional landscape of the mammalian genome.

Authors:  P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

10.  Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions.

Authors:  G Terry; L Ho; P Londesborough; J Cuzick
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

View more
  237 in total

Review 1.  Biomedical impact of splicing mutations revealed through exome sequencing.

Authors:  Bahar Taneri; Esra Asilmaz; Terry Gaasterland
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

2.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

3.  An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.

Authors:  Natalia N Singh; Katrin Hollinger; Dhruva Bhattacharya; Ravindra N Singh
Journal:  RNA       Date:  2010-04-22       Impact factor: 4.942

Review 4.  Alternative splicing and evolution: diversification, exon definition and function.

Authors:  Hadas Keren; Galit Lev-Maor; Gil Ast
Journal:  Nat Rev Genet       Date:  2010-04-08       Impact factor: 53.242

5.  Role of SFRS13A in low-density lipoprotein receptor splicing.

Authors:  I-Fang Ling; Steven Estus
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

Review 6.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

7.  Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes.

Authors:  Stefania Zampieri; Emanuele Buratti; Silvia Dominissini; Anna Lisa Montalvo; Maria Gabriela Pittis; Bruno Bembi; Andrea Dardis
Journal:  Eur J Hum Genet       Date:  2010-12-22       Impact factor: 4.246

8.  A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.

Authors:  Sophia Adamia; Benjamin Haibe-Kains; Patrick M Pilarski; Michal Bar-Natan; Samuel Pevzner; Herve Avet-Loiseau; Laurence Lode; Sigitas Verselis; Edward A Fox; John Burke; Ilene Galinsky; Ibiayi Dagogo-Jack; Martha Wadleigh; David P Steensma; Gabriela Motyckova; Daniel J Deangelo; John Quackenbush; Richard Stone; James D Griffin
Journal:  Clin Cancer Res       Date:  2013-11-27       Impact factor: 12.531

9.  Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND).

Authors:  Calixto-Hope Lucas; Mathilde Calvez; Roshni Babu; Amanda Brown
Journal:  Neurosci Lett       Date:  2013-11-08       Impact factor: 3.046

10.  Sex-specific and lineage-specific alternative splicing in primates.

Authors:  Ran Blekhman; John C Marioni; Paul Zumbo; Matthew Stephens; Yoav Gilad
Journal:  Genome Res       Date:  2009-12-15       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.